1 results
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Indication: Reduce risk ... Drug Class: Selective ... Eosinophils < 100 Dosing ... : 250 mcg tablet ... to reduce the risk